Canon Medical Systems established the Japanese joint venture — called ACTmed — with Taiwanese molecular diagnostics firm ACT Genomics.
The exclusive deal includes sales and marketing of a rapid thermal cycler as well as consumable microplates and pipette tips.
The deal covers Canon BioMedical's Novallele line of genotyping and copy number assays in Austria, Germany, and Switzerland.
Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon's Novallele assays and controls.
The method uses chitosan-coated magnetic beads and bead-based lysis to reduce the number of sample prep steps.
The companies have been working together since early 2015 on a diagnostic for the early detection of Lyme disease.
The firm has launched genotyping assays that rely on PCR followed by high-resolution melt analysis, as well as master mix companion chemistry.
The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing.
Among Canon BioMedical's life science projects is a genetic testing platform based on ultra-fast serial PCR and high-resolution melt analysis.
The partners will work together to build a rapid diagnostic test panel for Lyme Disease using T2's magnetic resonance detection technology.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.